PLoS Pathogens (Aug 2023)

Contrasting effects of filamin A and B proteins in modulating filovirus entry.

  • Ariel Shepley-McTaggart,
  • Jingjing Liang,
  • Yang Ding,
  • Marija A Djurkovic,
  • Valeriia Kriachun,
  • Olena Shtanko,
  • Oriol Sunyer,
  • Ronald N Harty

DOI
https://doi.org/10.1371/journal.ppat.1011595
Journal volume & issue
Vol. 19, no. 8
p. e1011595

Abstract

Read online

Ebola (EBOV) and Marburg viruses (MARV) cause severe hemorrhagic fever associated with high mortality rates in humans. A better understanding of filovirus-host interactions that regulate the EBOV and MARV lifecycles can provide biological and mechanistic insight critical for therapeutic development. EBOV glycoprotein (eGP) and MARV glycoprotein (mGP) mediate entry into host cells primarily by actin-dependent macropinocytosis. Here, we identified actin-binding cytoskeletal crosslinking proteins filamin A (FLNa) and B (FLNb) as important regulators of both EBOV and MARV entry. We found that entry of pseudotype psVSV-RFP-eGP, infectious recombinant rVSV-eGP-mCherry, and live authentic EBOV and MARV was inhibited in filamin A knockdown (FLNaKD) cells, but was surprisingly enhanced in filamin B knockdown (FLNbKD) cells. Mechanistically, our findings suggest that differential regulation of macropinocytosis by FLNa and FLNb likely contributes to their specific effects on EBOV and MARV entry. This study is the first to identify the filamin family of proteins as regulators of EBOV and MARV entry. These findings may provide insight into the development of new countermeasures to prevent EBOV and MARV infections.